# JAK1/JAK2 inhibition by baricitinib in diabetic kidney disease: results from a Phase 2 randomized controlled clinical trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/jak1-jak2-inhibition-by-baricitinib-in-diabetic-kidney-disease-results-from-a/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Katherine R Tuttle,Frank C. Brosius,Sharon G. Adler,Matthias Kretzler,Ravindra L. Mehta,James A. Tumlin,Yoshiya Tanaka,Masakazu Haneda,Jiajun Liu,Maria Silk,Tracy Cardillo,Kevin L. Duffin,Joseph V. Haas,William L. Macias,Fabio P. Nunes,Jonathan Janes |
| Citations | 284 |
| DOI | 10.1093/ndt/gfx377 |
| Fields | Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://academic.oup.com/ndt/article-pdf/33/11/1950/26182538/gfx377.pdf |
| OpenAlex ID | https://openalex.org/W2790867818 |
| PMID | 29481660 |
| Type | article |
| Year | 2017 |

## Paper authors

- [Yoshiya Tanaka](https://scholariq.org/researchers/yoshiya-tanaka/)
- [Kevin L. Duffin](https://scholariq.org/researchers/kevin-l-duffin/)
- [Matthias Kretzler](https://scholariq.org/researchers/matthias-kretzler/)

## Paper journal

- [Nephrology Dialysis Transplantation](https://scholariq.org/journals/nephrology-dialysis-transplantation/)

## Paper primary topic

- [Chronic Kidney Disease and Diabetes](https://scholariq.org/topics/chronic-kidney-disease-and-diabetes/)

## Paper topics

- [Chronic Kidney Disease and Diabetes](https://scholariq.org/topics/chronic-kidney-disease-and-diabetes/)
- [Cytokine Signaling Pathways and Interactions](https://scholariq.org/topics/cytokine-signaling-pathways-and-interactions/)
- [Myeloproliferative Neoplasms: Diagnosis and Treatment](https://scholariq.org/topics/myeloproliferative-neoplasms-diagnosis-and-treatment/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.